Comparison of two intranasal triamcinolone acetonide formulations in patients with seasonal or perennial allergic rhinitis Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
Evaluation of fluticasone (flixonase) nasal spray versus beclomethasone (beconase) nasal spray in the treatment of allergic rhinitis Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
A comparison of oral loratadine and fluticasone propionate aqueous nasal spray plus oral loratadine in the treatment of atopic cough associated with seasonal allergic rhinitis (SAR) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
A comparison of the efficacy of beclomethasone dipropionate (BDP) and fluticasone propionate (FP) aqueous nasal spray on symptoms and quality of life in perennial allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 110s Year: 2003
Triamcinolon acetonide nasal spray alone or in combination with loratidin in school children with severe seasonal allergic rhinitis and astma Source: Eur Respir J 2003; 22: Suppl. 45, 284s Year: 2003
Efficacy and safety of levocetirizine in persistent allergic rhinitis (PER) Source: Eur Respir J 2005; 26: Suppl. 49, 136s Year: 2005
Early treatment of perennial rhinitis with budesonide or cetirizine: effect on nasal inflammation Source: Eur Respir J 2002; 20: Suppl. 38, 92s Year: 2002
A comparison of fluticasone propionate (FP) and mometasone furoate (MF) nasal spray in the treatment of nasal polyposis associated with asthma Source: Eur Respir J 2006; 28: Suppl. 50, 314s Year: 2006
Combination of montelukast and loratadine provides added benefit for relief of symptoms of seasonal allergic rhinitis (SAR) Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
The role of topical nasal steroids (TNS) in the treatment of bronchial asthma (BA) combined with nasal polyposis (NP) Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004
Budesonide nasal spray alone or in combination with cetirizine in patients with severe seasonal allergic rhinitis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 45s Year: 2002
Efficacy of levocetirizine in perennial allergic rhinitis (PAR) as measured by the number of comfortable days Source: Eur Respir J 2004; 24: Suppl. 48, 124s Year: 2004
Evaluation of the immunogenicity and safety of a new formulation of omalizumab (solution for injection) in patients with allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects. Source: International Congress 2019 – New towards old therapies in airway diseases Year: 2019
Antihistamines (cetirizine and loratadine) and antileukotriene (montelukast) in the prevention of allergic rhinitis symptoms Source: Eur Respir J 2003; 22: Suppl. 45, 103s Year: 2003
Higher cellular retention and activity after pulse exposure by budesonide (BUD) than fluticasone propionate (FP) and mometasone furoate (MF) Source: Eur Respir J 2001; 18: Suppl. 33, 158s Year: 2001
Is the sequence of salmeterol (SM) and fluticasone p. (FP) dry powder inhalation crucial in persistent mild asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 45s Year: 2002
The effect of topical nasal budesonide (BUD) on Epworth sleepiness scale (ESS), fatigue, and performance in perennial allergic rhinitis (PAR) Source: Eur Respir J 2002; 20: Suppl. 38, 218s Year: 2002
Fluticasone furoate (FF), a novel inhaled corticosteroid (ICS), demonstrates once-daily (OD) efficacy in asthma when dosed in the evening Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
Mometasone furoate nasal spray compared with loradatine in school children with seasonal allergic rhinitis Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010